Related Experiment Video
Updated: Feb 18, 2026

08:45
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
1.6K
Thromboelastography as a Predictor of Outcomes Following Liver Transplantation
C L Trautman1, W C Palmer2, C B Taner3
1Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida.
Transplantation Proceedings
|November 19, 2017
Summary
Thromboelastography (TEG) monitoring after liver transplantation (LT) can predict longer hospital stays and early allograft dysfunction. TEG results may help identify high-risk patients for better outcomes.
Area of Science:
- Hepatology
- Transplantation Medicine
- Critical Care Medicine
Background:
- Thromboelastography (TEG) is utilized perioperatively in liver transplantation (LT) for real-time hemostasis assessment.
- It guides targeted blood product replacement during and after LT procedures.
Purpose of the Study:
- To investigate the correlation between post-LT TEG parameters and patient outcomes.
- To determine if TEG can predict complications following liver transplantation.
Main Methods:
- Retrospective analysis of 441 adult, first-time, single-organ LT patients from Mayo Clinic Florida (2008-2014).
- TEG parameters (r time, k time, α angle, maximum amplitude) were measured within 24 hours post-LT.
- Outcomes assessed included reoperation for bleeding, hospitalization duration, survival, and early allograft dysfunction.
Main Results:
- Prolonged or lengthening r time, k time, and r+k time were independently linked to increased hospitalization length.
- Elevated maximum amplitude on initial post-LT TEG correlated with early allograft dysfunction.
- No significant associations were found between TEG parameters and survival or return to the operating room for bleeding.
Conclusions:
- Changes in absolute and temporal TEG values are associated with prolonged hospitalization and early allograft dysfunction post-LT.
- TEG may serve as a valuable tool for identifying liver transplant recipients at higher risk for specific adverse outcomes.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Venous Thrombosis III: Interprofessional Care
388
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
Ultrasound II: Endoscopic Ultrasound and FibroScan
805
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
805

